HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Autotransfusion of red blood cell from cardiopulmonary bypass circuit blood after cardiac surgery].

AbstractOBJECTIVE:
The aim of this study was to evaluate the effect of autologous centrifuged residual cardiopulmonary bypass blood on patients' hematocryte value, donor blood product requirements, postoperative blood loss, hospitalization time and the development of infective complications.
MATERIAL AND METHODS:
Patients undergoing coronary artery bypass grafting or/and mitral valve procedures were divided into 3 groups. In group I (37 pts.) patients received all blood salvaged from the extracorporeal circuit at the end of cardiopulmonary bypass. In group II (45 pts.) patients blood was not re-infused. In group III (42 pts.) the residual pump blood was collected from the bypass circuit and spun at 2.600 rpm for 10-15 min. The clear upper supernatant was discarded and the remaining concentrated red cells were re-infused back to the patient.
RESULTS:
In all three groups hematocryte value during the first hour and postoperative blood loss during the first 12 hours after operation was similar. A higher hematocryte value was found in patients of group III after 12 hours postoperatively as compared with group I and group II (13.2% and 11.1% respectively, p<0.05). Furthermore, 28.57% patients in the group III required a blood transfusion compared with 37.83% patients in the group I and 38.10% patients in the group II (p<0.05). Patients in the group III developed less infective complications as compared with the group II the group I (10.3% and 4.3% respectively). Hospitalization time in group III was decreased in 25.8% as compared with the group I.
CONCLUSIONS:
We found that autologous centrifuged residual cardiopulmonary bypass blood was useful in avoiding infective complications, decreasing need of donor blood product requirement and postoperative length of stay in the hospital. This method increases hematocryte value after 12 hours postoperatively.
AuthorsTadas Lenkutis, Audrone Veikutiene, Laima Raliene, Jonas Surkus
JournalMedicina (Kaunas, Lithuania) (Medicina (Kaunas)) Vol. 38 Suppl 2 Pg. 213-6 ( 2002) ISSN: 1648-9144 [Electronic] Switzerland
Vernacular TitleEritrocitu mases, paruostos is dirbtines kraujo apytakos aparate likusio kraujo, panaudojimo tikslingumas ligoniams po sirdies operaciju.
PMID12560664 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
Topics
  • Blood Loss, Surgical (prevention & control)
  • Blood Transfusion, Autologous
  • Cardiopulmonary Bypass
  • Coronary Artery Bypass
  • Data Interpretation, Statistical
  • Erythrocyte Transfusion
  • Hematocrit
  • Humans
  • Intensive Care Units
  • Length of Stay
  • Mitral Valve (surgery)
  • Postoperative Care
  • Postoperative Complications (prevention & control)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: